A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer
- PMID: 33883932
- PMCID: PMC8053601
- DOI: 10.2147/BCTT.S268401
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer
Abstract
Breast cancer is the most common cancer diagnosis in women aged less than 40 years and the second most common cause of cancer death in this age group. Global rates of young onset breast cancer have risen steadily over the last twenty years. Although young women with breast cancer have a higher frequency of underlying pathogenic mutations in high penetrance breast cancer susceptibility genes (CSG) than older women, the vast majority of young breast cancer patients are not found to have a germline CSG mutation. There is therefore a need to inform young women regarding non-genetic breast cancer risk factors which have the potential to be influenced by changes in individual behaviour. A Pubmed search was performed using the search terms "young" or "early onset", and "breast cancer" and "modifiable risk". Titles and abstracts from peer-reviewed publications were screened for relevance. This review presents evidence for potentially modifiable risk factors of breast cancer risk in young women, including lifestyle factors (physical activity, body habitus, alcohol use, smoking, shift work and socioeconomic factors), reproductive and hormonal factors and iatrogenic risks. The extent to which these factors are truly modifiable is discussed and interactions between genetic and non-genetic risk factors are also addressed. Health care professionals have an opportunity to inform young women about breast health and risk when presenting at a "teachable moment", including the benefits of physical activity and alcohol habits as risk factor. More focussed discussions regarding individual personal risk and benefit should accompany conversations regarding reproductive health and take into consideration both non-modifiable and iatrogenic BC risk factors.
Keywords: breast cancer; lifestyle; modifiable; prevention; risk factors; young.
© 2021 Daly et al.
Conflict of interest statement
Prof. Ramsey I Cutress reports non-financial support from SECA, outside the submitted work. Dr Ellen R Copson reports grants, personal fees from World Cancer Research Fund, non-financial support from SECA, personal fees from AstraZeneca, personal fees from Roche, personal fees from Lilly, personal fees from Pfizer, personal fees from Nanostring, personal fees from Novartis, outside the submitted work. Prof. Cutress and Dr Copson report research funding from World Cancer Research Fund (WCRF UK) as part of the WCRF International grant programme . The authors report no other conflicts of interest in this work.
Similar articles
-
Mechanisms underlying social inequality in post-menopausal breast cancer.Dan Med J. 2014 Oct;61(10):B4922. Dan Med J. 2014. PMID: 25283627
-
Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study.Breast Cancer Res Treat. 2017 Jan;161(2):311-320. doi: 10.1007/s10549-016-4047-x. Epub 2016 Nov 10. Breast Cancer Res Treat. 2017. PMID: 27832394
-
Alcohol use and breast cancer risk: A qualitative study of women's perspectives to inform the development of a preventative intervention in breast clinics.Eur J Cancer Care (Engl). 2019 Jul;28(4):e13075. doi: 10.1111/ecc.13075. Epub 2019 Apr 30. Eur J Cancer Care (Engl). 2019. PMID: 31038252 Free PMC article.
-
Modifiable Risk Factors for the Development of Breast Cancer in Young Women.Cancer J. 2018 Nov/Dec;24(6):275-284. doi: 10.1097/PPO.0000000000000340. Cancer J. 2018. PMID: 30480572 Review.
-
The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis.Cancer Causes Control. 2020 May;31(5):403-416. doi: 10.1007/s10552-020-01284-2. Epub 2020 Mar 4. Cancer Causes Control. 2020. PMID: 32130573
Cited by
-
Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer.3 Biotech. 2022 Mar;12(3):70. doi: 10.1007/s13205-022-03121-6. Epub 2022 Feb 13. 3 Biotech. 2022. PMID: 35223356 Free PMC article. Review.
-
What Causes Cancer in Women with a gBRCA Pathogenic Variant? Counselees' Causal Attributions and Associations with Perceived Control.Genes (Basel). 2022 Aug 6;13(8):1399. doi: 10.3390/genes13081399. Genes (Basel). 2022. PMID: 36011311 Free PMC article.
-
Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study.J Pers Med. 2021 May 8;11(5):387. doi: 10.3390/jpm11050387. J Pers Med. 2021. PMID: 34066838 Free PMC article.
-
Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data Analysis.Cancer Epidemiol Biomarkers Prev. 2023 Dec 1;32(12):1738-1746. doi: 10.1158/1055-9965.EPI-23-0520. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37733340 Free PMC article.
-
Trends, key contributors, and emerging issues in honey and breast cancer: A bibliometric analysis from 2014 to 2024.F1000Res. 2025 Mar 24;14:17. doi: 10.12688/f1000research.159595.3. eCollection 2025. F1000Res. 2025. PMID: 40212986 Free PMC article. Review.
References
-
- Global Cancer Observatory (GLOBOCAN). Global cancer observatory. Cancer Today- International Agency for Research on Cancer: World Health Organisation; 2018. Available from: https://gco.iarc.fr/today/home. Accessed November3, 2020.
-
- U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool; June, 2020. Available from: https://gis.cdc.gov/Cancer/USCS/DataViz.html. Accessed November3, 2020.
-
- Cancer Research UK. Breast cancer statistics UK: cancer research UK; 2016. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s.... Accessed November3, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources